Between NSCLC with BRAF V600E mutation and non-V600E alterations, PFS and overall response rate were not significantly different, although NSCLC with BRAF V600E mutation exhibited lower TMB compared with those harboring non-V600E alterations [85] (Figure 1). Here, BRAF is linked to non-small cell lung carcinoma.